Form 4 Tracker
Hims & Hers Health, Inc.
HIMS

92 insider filings · Latest: Oct 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 14, 2025Jul 14 4:25 PMBoughton Soleil
Proposed Sale
2,572$47.82$123.0K—

View →

Jul 8, 2025Jul 8 8:48 PMMelissa Baird
Proposed Sale
33,333$48.96$1.6M—

View →

Jun 30, 2025Jun 30 2:56 PMBoughton Soleil
Proposed Sale
2,572$50.50$129.9K—

View →

Jun 23, 2025Jun 23 8:49 PMOluyemi Okupe
Proposed Sale
69,431$41.98$2.9M—

View →

Jun 17, 2025Jun 17 4:42 PMChi Michael
Proposed Sale
17,102$59.75$1.0M—

View →

Jun 17, 2025Jun 17 4:13 PMDudum Andrew
Proposed Sale
65,110$59.22$3.9M—

View →

Jun 17, 2025Jun 17 3:19 PMBecklund Irene
Proposed Sale
8,485$59.75$507.0K—

View →

Jun 17, 2025Jun 17 2:20 PMBoughton Soleil
Proposed Sale
2,572$59.75$153.7K—

View →

Jun 16, 2025Jun 16 9:58 PMMelissa Baird
Proposed Sale
33,333$59.78$2.0M—

View →

Jun 16, 2025Jun 16 6:42 PMDudum Andrew
Proposed Sale
47,534$56.49$2.7M—

View →

Jun 16, 2025Jun 16 3:53 PMBoughton Soleil
Proposed Sale
5,451$56.80$309.6K—

View →

Jun 16, 2025Jun 16 3:24 PMDudum Andrew
Proposed Sale
128,127$56.43$7.2M—

View →

Jun 10, 2025Jun 10 4:12 PMChi Michael
Proposed Sale
5,400$57.00$307.8K—

View →

Jun 6, 2025Jun 6 5:19 PMChi Michael
Proposed Sale
5,100$56.00$285.6K—

View →

Jun 4, 2025Jun 4 8:46 PMMelissa Baird
Proposed Sale
33,333$53.61$1.8M—

View →

May 27, 2025May 27 8:44 PMMelissa Baird
Proposed Sale
33,333$53.36$1.8M—

View →

May 27, 2025May 27 3:12 PMBoughton Soleil
Proposed Sale
3,233$55.87$180.6K—

View →

May 22, 2025May 22 1:45 PMBecklund Irene
Proposed Sale
5,071$53.51$271.3K—

View →

May 16, 2025May 16 3:08 PMDudum Andrew
Proposed Sale
175,661$58.36$10.3M—

View →

May 12, 2025May 12 9:10 PMMelissa Baird
Proposed Sale
33,333$55.21$1.8M—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 22, 2026Sep 23 8:17 PMOluyemi OkupeChief Financial Officer
Option Exercise
14,000$5.0166,872(D)

View →

Aug 19, 2026Aug 20 8:30 PMOluyemi OkupeChief Financial Officer
Option Exercise
4,938$5.0180,872(D)

View →

Aug 14, 2026Aug 18 9:04 PMSoleil BoughtonChief Legal Officer
Option Exercise
42,261—164,598(D)

View →

Aug 14, 2026Aug 18 9:04 PMKare SchultzDirector
Option Exercise
6,623—6,624(D)

View →

Aug 14, 2026Aug 18 9:04 PMPatrick Harrison CarrollChief Medical Officer
Option Exercise
26,187—131,678(D)

View →

Aug 14, 2026Aug 18 9:04 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Option Exercise
154,993—362,114(D)

View →

Aug 14, 2026Aug 18 9:04 PMMichael ChiChief Operating Officer
Option Exercise
86,265—329,194(D)

View →

Aug 17, 2026Aug 18 9:04 PMOluyemi OkupeChief Financial Officer
Option Exercise
9,388$5.0185,810(D)

View →

Aug 14, 2026Aug 18 9:04 PMOluyemi OkupeChief Financial Officer
Option Exercise
71,616—263,356(D)

View →

Aug 14, 2026Aug 18 9:04 PMDeborah M. AutorDirector, Chief Policy Officer
Option Exercise
32,920—427,953(D)

View →

Aug 14, 2026Aug 18 9:03 PMDavid B WellsDirector
Option Exercise
778—0(D)

View →

Aug 14, 2026Aug 18 9:03 PMMohamed ElshenawyCTO
Option Exercise
188,285—1,100,000(D)

View →

Aug 14, 2026Aug 18 9:03 PMIrene BecklundPAO
Option Exercise
13,685—54,317(D)

View →

Aug 14, 2026Aug 18 9:03 PMChristopher D PayneDirector
Option Exercise
545—0(D)

View →

Aug 12, 2026Aug 14 8:16 PMMohamed ElshenawyCTO
Grant/Award
1,200,000—1,200,000(D)

View →

Aug 12, 2026Aug 14 8:16 PMKare SchultzDirector
Grant/Award
8,223—8,223(D)

View →

Aug 12, 2026Aug 14 8:16 PMChristopher D PayneDirector
Grant/Award
8,768—545(D)

View →

Aug 12, 2026Aug 14 8:15 PMGarcia Andrea G PerezDirector
Grant/Award
8,223—8,223(D)

View →

Aug 12, 2026Aug 14 8:15 PMAnja ManuelDirector
Grant/Award
8,223—8,223(D)

View →

Aug 12, 2026Aug 14 8:15 PMDelos M. CosgroveDirector
Grant/Award
8,223—8,223(D)

View →

Page 1 of 4

Next →